Retrospective audit of 957 consecutive 18 F-FDG PET –CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma

ConclusionsPET –CT in high-grade bone and soft tissue sarcoma can add significant benefit to routine CT/MRI staging. Further prospective and multi-centre evaluation of PET–CT is warranted to determine the actual predictive value and cost-effectiveness of PET–CT in directing clinical management of clinically complex and heterogeneous high-grade sarcomas.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research